Phase
Condition
Claudication
Peripheral Vascular Disease
Peripheral Arterial Occlusive Disease
Treatment
MagicTouch PTA sirolimus drug coated balloon (DCB)
POBA standard balloon
Clinical Study ID
Ages > 21 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥ 21 years or minimum age
- Rutherford class 3 to 6 in the target limb Intraoperative Inclusion Criteria
- Single or sequential de novo or re-stenotic lesions (stenosis of > 50% or occlusions)from 2 to 20cm in the femoropopliteal arteries. Lesion is considered as one lesion ifthere is maximum of 30mm gap between lesions at discretion of investigator.Femoropopliteal arteries are superficial femoral artery, popliteal artery P1 and P2
- Inflow free from flow limiting lesions (<50% stenosis) confirmed by duplex orangiography. Subjects with flow limiting inflow lesions (>50% stenosis) can beincluded if lesion had been treated successfully (<30% residual stenosis) before orduring the index procedure.
- At least one non-occluded crural vessel (ie. without significant stenosis) withangiographically documented run off to the foot.
Exclusion
Exclusion Criteria:
- Comorbid conditions limiting life expectancy ≤ 1 year
- Subject is currently participating in another investigational drug or device studythat has not reached first primary endpoint yet
- Subject is pregnant or planning to become pregnant during the course of the study
- Heel gangrene
- Prior bypass surgery of target vessel
- Planned amputation of the target limb
- Previously implanted stent in the target lesion
- Vulnerable or protected adults
- Bleeding diathesis or another disorder such as gastrointestinal ulceration whichrestrict the use of clopidogrel or aspirin
- Known allergy to sirolimus Intraoperative Exclusion Criteria
- Failure to successfully cross the target lesion with a guide wire (successful crossingmeans tip of the guide wire distal to the target lesion in the absence of flowlimiting dissections or perforations)
- Failure to obtain <30% residual stenosis in a pre-existing lesion
- Highly calcific lesions
- Use of DCBs, drug eluting stent, specialty balloons or artherectomy devices during theindex procedure. (Non-compliant balloons are not considered specialty balloons)
- Lesions requiring retrograde access (SAFARI)
Study Design
Study Description
Connect with a study center
Asan Medical Centre
Seoul,
Korea, Republic ofSite Not Available
Khoo Teck Puat Hospital
Singapore,
SingaporeActive - Recruiting
National University Hospital
Singapore,
SingaporeActive - Recruiting
Ng Teng Fong General Hospital
Singapore,
SingaporeSite Not Available
Sengkang General Hospital
Singapore,
SingaporeActive - Recruiting
Singapore General Hospital
Singapore,
SingaporeActive - Recruiting
Tan Tock Seng Hospital
Singapore,
SingaporeActive - Recruiting
Far Eastern Memorial Hospital
New Taipei City,
TaiwanSite Not Available
Taipei Tzuchi Hospital
New Taipei City,
TaiwanSite Not Available
National Taiwan University Hospital
Taipei City,
TaiwanSite Not Available
Shin Kong Wu Ho-Su Memorial Hospital
Taipei City,
TaiwanSite Not Available
Taipei Mackay Memorial Hospital
Taipei City,
TaiwanSite Not Available
Linkou Chang Gung Memorial Hospital
Taoyuan City,
TaiwanSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.